Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03907410 · ClinicalTrials.gov registry record · NA
The Tailored Adherence Incentives for Childhood Asthma Medications (TAICAM) Trial
A NA study, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- NA
- Development phase
- 125
- Enrollment target
NCT03907410 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 125 participants.
The verdict
NCT03907410, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- NA
- Development phase
- 125 participants
- Enrollment target
Study Summary
Improving adherence to inhaled corticosteroids (ICS) medication in urban minority pediatric populations is a clinical and population health priority. Financial incentives have been shown as a compelling method to engage a high-risk asthma population in regular ICS use, but whether and how adherence can be maintained and lead to sustained high adherence trajectories is unknown.
Interventions
- OTHER Nominal Financial Incentives
- OTHER Daily Adherence Reminders/Adherence Performance Feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2022-07-17 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03907410
The ClinicalTrials.gov registry entry for NCT03907410 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Nominal Financial Incentives is the first listed.
NCT03907410 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03907410 about?
NCT03907410 is a clinical study titled "The Tailored Adherence Incentives for Childhood Asthma Medications (TAICAM) Trial". Improving adherence to inhaled corticosteroids (ICS) medication in urban minority pediatric populations is a clinical and population health priority. Financial incentives have been shown as a compelling method to engage a high-risk asthma population in regular ICS use, but whether and how adherence ...
What is the current status of trial NCT03907410?
This trial is currently completed. It is a NA study. The enrollment target is 125 participants. The study started on 2019-09-01. Estimated completion is 2022-07-17.
What interventions are being tested in trial NCT03907410?
The interventions under investigation include: Nominal Financial Incentives (OTHER), Daily Adherence Reminders/Adherence Performance Feedback (OTHER).
Who is sponsoring clinical trial NCT03907410?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.